Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$36.81 - $48.12 $16,638 - $21,750
452 New
452 $18,000
Q2 2022

Aug 10, 2022

BUY
$46.84 - $59.75 $190,545 - $243,063
4,068 New
4,068 $200,000
Q1 2022

Apr 25, 2022

SELL
$48.09 - $57.79 $194,379 - $233,587
-4,042 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.19 - $62.68 $190,741 - $253,352
4,042 New
4,042 $212,000
Q4 2020

Feb 11, 2021

SELL
$43.41 - $56.51 $9.61 Million - $12.5 Million
-221,388 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$32.82 - $81.13 $628,437 - $1.55 Million
19,148 Added 9.47%
221,388 $11.2 Million
Q4 2019

Feb 14, 2020

SELL
$60.96 - $77.7 $2.28 Million - $2.9 Million
-37,353 Reduced 15.59%
202,240 $15.6 Million
Q3 2019

Oct 30, 2019

SELL
$55.78 - $68.08 $44,233 - $53,987
-793 Reduced 0.33%
239,593 $15.2 Million
Q2 2019

Aug 14, 2019

BUY
$53.69 - $65.47 $2.11 Million - $2.58 Million
39,334 Added 19.56%
240,386 $14.1 Million
Q1 2019

May 14, 2019

BUY
$44.53 - $58.9 $8.52 Million - $11.3 Million
191,432 Added 1989.94%
201,052 $11.4 Million
Q4 2018

Feb 06, 2019

SELL
$47.64 - $71.26 $190 - $285
-4 Reduced 0.04%
9,620 $477,000
Q3 2018

Nov 15, 2018

SELL
$52.03 - $71.41 $284,656 - $390,684
-5,471 Reduced 36.24%
9,624 $683,000
Q2 2018

Aug 15, 2018

BUY
$48.15 - $56.68 $260,732 - $306,922
5,415 Added 55.94%
15,095 $787,000
Q1 2018

May 15, 2018

SELL
$46.03 - $61.28 $1.17 Million - $1.55 Million
-25,319 Reduced 72.34%
9,680 $505,000
Q4 2017

Feb 14, 2018

SELL
$50.58 - $60.79 $1.04 Million - $1.25 Million
-20,524 Reduced 36.96%
34,999 $2.05 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $2.97 Million - $3.78 Million
55,523
55,523 $3.08 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.